RBC Capital Sticks to Their Buy Rating for Incitec Pivot Limited (ICPVF)
In a report released on February 10, Owen Birrell from RBC Capital maintained a Buy rating on Incitec Pivot Limited (ICPVF – Research Report), ...
UBS cuts Edgewell Personal Care target to $31, keeps neutral rating
UBS analyst Peter Grom revised the price target for Edgewell Personal Care (NYSE:EPC) shares, reducing it to $31 from $36, while maintaining a Neutral rating on the stock. The adjustment follows ...
UBS maintains Buy on Inspire Medical stock, target at $265
Tuesday, analysts at UBS reaffirmed their positive stance on Inspire Medical Systems (NYSE:INSP), maintaining a Buy rating and a price target of $265.00. This aligns with the broader Wall Street ...
RBC Capital Remains a Hold on Kering SA (0IIH)
RBC Capital analyst Piral Dadhania maintained a Hold rating on Kering SA (0IIH – Research Report) today and set a price target of €240.00. The ...
Investing7d
UBS beats profit forecast as Investment Banking outperforms in Q4
Investing.com -- UBS on Tuesday posted a stronger-than-expected performance in the fourth quarter, reporting a net profit of ...
Barrenjoey poaches managing director from RBC Capital Markets
Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his ...
Seeking Alpha7d
UBS targets 2025 return on CET1 capital of 10% amid integration progress
Anke Reingen, RBC: Questioned U.S. wealth management ... Jeremy Sigee, BNP Paribas: Inquired about capital markets revenue and UBS Americas CET1 ratio reductions. Tuckner highlighted the timing ...